UiPath Inc. (NYSE:PATH) Receives Average Rating of “Hold” from Brokerages

Shares of UiPath Inc. (NYSE:PATH) have been given a consensus recommendation of “Hold” by the eighteen research firms that are covering the firm, Marketbeat.com reports. Sixteen analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $17.47.

A number of equities analysts have recently weighed in on PATH shares. Barclays upped their price target on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Friday, September 6th. Wells Fargo & Company cut their price target on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a research note on Wednesday. Bank of America lifted their price target on UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Needham & Company LLC restated a “hold” rating on shares of UiPath in a report on Wednesday. Finally, DA Davidson lifted their target price on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Friday, September 6th.

UiPath Price Performance

NYSE:PATH opened at $12.34 on Friday. The stock’s 50-day moving average is $12.50 and its two-hundred day moving average is $14.15. The stock has a market cap of $6.79 billion, a PE ratio of -61.70 and a beta of 0.88. UiPath has a fifty-two week low of $10.37 and a fifty-two week high of $27.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same period in the previous year, the firm posted ($0.09) earnings per share. The firm’s revenue was up 10.0% on a year-over-year basis. On average, equities research analysts anticipate that UiPath will post -0.23 earnings per share for the current year.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 22.37% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in PATH. ORG Partners LLC grew its stake in shares of UiPath by 875.6% in the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares during the last quarter. Future Financial Wealth Managment LLC bought a new stake in UiPath in the 3rd quarter valued at $26,000. JTC Employer Solutions Trustee Ltd acquired a new stake in UiPath in the 3rd quarter worth $26,000. Hantz Financial Services Inc. bought a new position in shares of UiPath during the 2nd quarter worth about $28,000. Finally, Advisors Asset Management Inc. increased its holdings in shares of UiPath by 35.0% during the 1st quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock worth $69,000 after purchasing an additional 787 shares during the period. 62.50% of the stock is owned by institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.